Eddit

Version vom 20. Mai 2020, 12:27 Uhr

• Further reading
• Unproven ideas
• Reviews on covid19 disease

32371564 2020. Clinical presentation and course of COVID-19
32366502 2020. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies
32252141 2020. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)
32252139 2020. Epidemiology and clinical features of coronavirus disease 2019 in children
32207680 2020. COVID-19: the new challenge for rheumatologists
32197957 ä. What Should Gastroenterologists and Patients Know About COVID-19?
32276137 ä. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
32325252 2020. COVID-19 pathophysiology: A review

• Research tools
• Structure of covid19

32311462 2020. On the molecular determinants of the SARS-CoV-2 attack
32129843 ä. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients
32129842 ä. A glimpse into the origins of genetic diversity in SARS-CoV-2

• Target binding and uptake

32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections

• Cytopathic effects
• Secretion and shedding
• Innate sensing
• Immunology

32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32333860 2020. Presepsin in risk stratification of SARS-CoV-2 patients

• Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome

32145275 2020. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
32348783 2020. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
32202240 2020. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

• Microvascular
• Early symptoms
• Systemic disease, any manifestations

32358954 ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
32361747 ä. COVID-19, superinfections and antimicrobial development: What can we expect?

• ARDS

32173725 ä. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China

• Pulmonary embolism, coagulation

32250159 2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients

• Hematology

32178975 ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

• Heart

32371557 2020. SARS-CoV-2 and myocardial injury: Few answers, many questions

• Neurology, ophthalmology, orl

32357210 ä. Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19)
32215618 ä. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study

• Dermatology
• Gastroenterology, hepatology

32371556 2020. Hyperglycemia management in the critically ill patient with COVID-19
32205220 ä. Don t Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)
32278065 ä. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management
32334083 ä. Current Knowledge and Research Priorities in the Digestive Manifestations of COVID-19
32311512 ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19
32283325 ä. Clinical Features of COVID-19-Related Liver Damage

• Kidney, urology==
• Pathobiology

32334082 ä. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection

• Disease Models

32215622 ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility

• Similar diseases and pathomechanisms
• Diagnosis (Laboratory)

32360478 2020. Emerging key laboratory tests for patients with COVID-19
32077933 ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak
32154877 ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception
32246822 ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads
32353116 ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything
32343775 ä. SARS-CoV-2 Serology: Much Hype, Little Data
32315390 ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform
32282874 ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2)
32031590 ä. Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)
32229107 2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient
32031583 ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
32156607 ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020
32343948 2020. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
32335089 ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories
32315614 2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients
32295319 2020. Innovative screening tests for COVID-19 in South Korea
32358960 ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools
32357209 ä. Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection
32357206 ä. Role of serology in the COVID-19 pandemic
32221523 ä. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients
32221519 ä. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

• Diagnosis (Lung CT, Sonography)

32120312 2020. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease
32302927 2020. Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review
32361535 ä. COVID-19 pneumonia patient without clear epidemiological history outside Wuhan: An analysis of the radiographic and clinical features
32361413 2020. Initial CT imaging characters of an imported family cluster of COVID-19
32358955 ä. Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection
32232429 ä. Computed Tomographic Imaging of 3 Patients With Coronavirus Disease 2019 Pneumonia With Negative Virus Real-time Reverse-Transcription Polymerase Chain Reaction Test
32227091 ä. Novel Coronavirus Pneumonia (COVID-19) Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery
32198501 ä. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

• Diagnosis (other modalities)
• Clinical guidelines and advice

32283324 ä. COVID-19 ? Considerations for the paediatric rheumatologist

• Respiration mgmt

32371555 2020. Utility of extracorporeal membrane oxygenation in COVID-19

• Risk and special populations

32371563 2020. Asthma increases risk of severity of COVID-19
32360479 ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases
32360811 ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32249918 ä. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study
32215613 ä. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System?a Call for Epidemiologic Investigations
32182347 ä. Perinatal Transmissionof COVID-19 Associated SARS-CoV-2:Should We Worry?

• Case reports

32147731 ä. Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS
32227197 ä. A Community Transmitted Case of Severe Acute Respiratory Distress Syndrome due to SARS CoV2 in the United States
32211789 ä. The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area

• Case series

32308494 2020. Epidemiologic and Clinical Characteristics of 26 Cases of COVID-19 Arising from Patient-to-Patient Transmission in Liaocheng, China
32361723 ä. Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China
32361738 ä. Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China
32232322 ä. Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea
32211844 ä. Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan
32179890 ä. Risk Factors of Healthcare Workers with Corona Virus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China

32176772 ä. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China

• Trials
• Candidate Compounds Covid19

32371558 2020. Hydroxychloroquine use in the COVID-19 patient
32272008 2020. Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
32337664 ä. Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
32359035 2020. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19
32272196 2020. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
32247038 2020. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
32222466 2020. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
32360516 ä. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
32353634 2020. COVID-19: Immunology and treatment options
32335290 2020. A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection
32150618 ä. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
32211771 ä. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
32211764 ä. Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019?

• Remission, recurrence and persistence

32311512 ä. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19

• The morbid survivor
• Biophysics of aerosols
• Other routes of infection
• Passive protective equipment
• Running your hospital

32371561 2020. Pulmonary function testing precautions in a time of COVID-19
32371560 2020. PAP therapy increases the risk of transmission of COVID-19
32252508 2020. Sharing Our Experience of Operating an Endoscopy Unit in the Midst of a COVID-19 Outbreak
32371164 ä. RECOMMENDATIONS FOR ESSENTIAL ESOPHAGEAL PHYSIOLOGICTESTING DURING THE COVID-19 PANDEMIC
32304737 ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic

• Mental aspects of health professionals
• Socio-psychiatric aspects of the status hygienicus

32371559 2020. Helping children cope with the COVID-19 pandemic

• Avoiding clinical medicine in other diseases
• Occupational medicine, workplace security and status hygienicus
• Economic aspects of the status hygienicus
• Educational aspects of the status hygienicus
• Host, vector, one health, atmospheric aspects
• Origin of Covid19
• Epidemiology

32227121 ä. The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread
32201889 ä. COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China

• Failure of politics and public health guidance
• Failure of executive measures
• Political abuse of Covid19
• Lost people
• Lost civilization
• History of covid19 exploration
• Current state of coviki.org
• PubMed selected papers unsorted to be listed in contents topics
• coviki state of development
• misc.